These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 6196136)

  • 1. Intravesical chemotherapy in the United States. An overview.
    Spaulding JT
    Cancer Chemother Pharmacol; 1983; 11 Suppl():S5-8. PubMed ID: 6196136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravesical chemotherapy of superficial bladder cancer.
    Lum BL
    Recent Results Cancer Res; 1983; 85():3-36. PubMed ID: 6408716
    [No Abstract]   [Full Text] [Related]  

  • 3. [Intravesical chemotherapy for superficial bladder tumors].
    Ohmori H
    Gan To Kagaku Ryoho; 1984 Aug; 11(8):1557-62. PubMed ID: 6206797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravesical chemotherapy for superficial bladder cancer.
    Koontz WW
    Urology; 1984 Apr; 23(4 Suppl):79-81. PubMed ID: 6424298
    [No Abstract]   [Full Text] [Related]  

  • 5. Conservative treatment of diffuse carcinoma in situ of the bladder with repeated courses of intravesical therapy.
    Mukamel E; deKernion JB
    Br J Urol; 1989 Aug; 64(2):143-6. PubMed ID: 2504435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-year experience with intravesical therapy of carcinoma in situ: an inquiry into the risks of "conservative" management.
    Stanisic TH; Donovan JM; Lebouton J; Graham AR
    J Urol; 1987 Nov; 138(5):1158-61. PubMed ID: 3118055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationale for intravesical chemotherapy in the treatment and prophylaxis of superficial transitional cell carcinoma.
    Soloway MS; Jordan AM; Murphy WM
    Prog Clin Biol Res; 1989; 310():215-36. PubMed ID: 2505268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitomycin-C and BCG in intravesical chemotherapy and immunotherapy of superficial bladder cancer. Finnbladder Research Group.
    Rintala E; Jauhiainen K; Alfthan O
    Prog Clin Biol Res; 1989; 310():271-4. PubMed ID: 2505270
    [No Abstract]   [Full Text] [Related]  

  • 9. Intravesical chemotherapy versus immunotherapy for superficial bladder cancer.
    Huben RP
    Semin Urol Oncol; 1996 Feb; 14(1 Suppl 1):17-22. PubMed ID: 8727806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Introduction and overview of intravesical therapy for superficial bladder cancer.
    Soloway MS
    Urology; 1988 Mar; 31(3 Suppl):5-16. PubMed ID: 3126593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgery and intravesical chemotherapy in the management of superficial bladder cancer.
    Soloway MS
    Semin Urol; 1983 Feb; 1(1):23-33. PubMed ID: 6433424
    [No Abstract]   [Full Text] [Related]  

  • 12. Intravesical therapy of low stage bladder carcinoma with mitomycin C: comparison of results in untreated and previously treated patients.
    Prout GR; Griffin PP; Nocks BN; DeFuria MD; Daly JJ
    J Urol; 1982 Jun; 127(6):1096-8. PubMed ID: 6806488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravesical therapy for bladder cancer.
    Soloway MS
    Urol Clin North Am; 1988 Nov; 15(4):661-9. PubMed ID: 3142129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rationale for intensive intravesical chemotherapy for superficial bladder cancer.
    Soloway MS
    J Urol; 1980 Apr; 123(4):461-6. PubMed ID: 6767860
    [No Abstract]   [Full Text] [Related]  

  • 15. Update on the Dutch Cooperative Trial: mitomycin versus bacillus Calmette-Guérin-Tice versus bacillus Calmette-Guérin RIVM in the treatment of patients with pTA-pT1 papillary carcinoma and carcinoma in situ of the urinary bladder. Dutch South East Cooperative Urological Group.
    Witjes WP; Witjes JA; Oosterhof GO; Debruyne MJ
    Semin Urol Oncol; 1996 Feb; 14(1 Suppl 1):10-6. PubMed ID: 8727805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sequential instillation therapy with mitomycin-C and adriamycin in superficial bladder tumor with special reference to fate of 43 patients achieving complete response].
    Fukui I; Sekine H; Kihara K; Yamada T; Kawai T; Washizuka M; Ishiwata D; Oka K; Hosoda K; Ikegami S
    Nihon Hinyokika Gakkai Zasshi; 1987 Sep; 78(9):1539-44. PubMed ID: 3127621
    [No Abstract]   [Full Text] [Related]  

  • 17. Intravesical chemotherapy: how effective is it?
    Heney NM
    Urology; 1988 Mar; 31(3 Suppl):17-9. PubMed ID: 3126591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of intravesical cisplatin and mitomycin-C for recurrent transitional cell carcinoma of bladder refractory to thiotepa.
    Mobley WC; Loening SA; Narayana AS; Culp DA
    Urology; 1986 Apr; 27(4):335-9. PubMed ID: 3083555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single and sequential combination intravesical chemotherapy of murine bladder cancer.
    Soloway MS; Nissenkorn I; McCallum LW; Murphy WM
    Urology; 1982 Feb; 19(2):169-75. PubMed ID: 6800090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravesical thiotepa and mitomycin C treatment immediately after transurethral resection and later for superficial (stages Ta and Tis) bladder cancer: a prospective, randomized, stratified study with crossover design.
    Zincke H; Benson RC; Hilton JF; Taylor WF
    J Urol; 1985 Dec; 134(6):1110-4. PubMed ID: 3932685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.